269 results
Page 11 of 14
8-K
EX-99.1
sh7778cwh tnbj6a85
12 Sep 11
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2011
12:00am
8-K
EX-99.1
qyn hfed876b0ar
6 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
idoqtx
24 Aug 11
Capital to be utilized in advancing the development of novel cancer diagnostic and therapeutic products
12:00am
8-K
EX-99.1
fwr4dlcxcovip9x
19 Aug 11
BioTime Receives NIH Approval for Four GMP Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
qyswpcdbxx9a
10 Aug 11
BioTime Announces Second Quarter 2011 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
lq8dio
19 Jul 11
BioTime Announces the Issuance of a Second U.S. Glycosan Hydrogel Patent
12:00am
8-K
4lmxj
19 Jul 11
BioTime Announces the Issuance of a Second U.S. Glycosan Hydrogel Patent
12:00am
8-K
EX-99.1
3i2e um9vztyocr
15 Jul 11
BioTime Receives $335,900 SBIR Grant
12:00am
8-K
EX-99.1
lapzhy
29 Jun 11
BioTime Announces Appointment of Chief Commercial Officer
12:00am
8-K
EX-99.1
89as4m ybaouge
9 Jun 11
Complete sequencing of DNA shows normality of the cells and their suitability for clinical use
12:00am
8-K
EX-99.1
wp328xl3tb
3 Jun 11
BioTime Receives NIH Approval for Two GMP Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
yochs98ylc
10 May 11
BioTime Announces Issuance of U.S. Glycosan Hydrogel Patent
12:00am
8-K
EX-99.1
ts31oulo05zdg r9
5 May 11
BioTime Announces First Quarter 2011 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
5etk5bmsbg2
3 May 11
BioTime Initiates Clinical Development Program for HyStem®-Rx as a Cell Delivery Device for Reconstructive Surgery and Other Cell-Based Therapies
12:00am
8-K
EX-99.1
fu7pxhbs
12 Apr 11
BioTime Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology
12:00am